Skip to content
Search

Latest Stories

Pharmacy bodies disappointed with launch date of Pharmacy Contraception Service

National pharmacy bodies have expressed their disappointment on the launch date for Tier 1 of the Pharmacy Contraception Service which has been announced by NHS England (NHSE) as '24th April 2023'.

Pharmaceutical Services Negotiating Committee (PSNC) said that this start date for the service has not been agreed with PSNC and is in direct contradiction of our warning to Ministers that no new or expanded services can be rolled out in 2023/24 unless extra funding is put into community pharmacies.


Responding to this announcement, PSNC Chief Executive Janet Morrison said: “This is despite our warning last month that without additional funding, the roll-out of Year 5 additional services and the Pharmacy Quality Scheme is neither feasible nor affordable. Community pharmacies are having to work harder and harder for less money and many are at breaking point. And just this week the results of our 2023 Pharmacy Pressures Survey have confirmed the worsening situation.

Clearly our view is not because contractors don’t see the benefit of the service. This is a much-anticipated service that could deliver real benefits to patients and community pharmacies are always eager to support public health initiatives. But capacity in the sector is now so stretched that more money is needed to safely resource additional work.

We have repeated our concerns to the Department in recent days and reminded them of the potential for a properly funded community pharmacy sector to play a greater role in providing clinical solutions and relieving pressures elsewhere in primary care.”

Dr Leyla Hannbeck CEO of AIMp also expressed her disappointment on the announcement as the sector is "barely able to keep its ahead above the water and with our workforce being exhausted we are being asked to deliver more services without any additional funding or resource."

She stressed: “It is also clear that the current PSNC approach is not working and it requires change. It must also be understood very clearly by both DH and PSNC that whether negotiated or imposed pharmacies need time to understand, plan and integrate new services into the very busy, business as usual days”.

“Our members have always been keen and proactive to deliver pharmacy services, but the current model where pharmacies are asked to do more for less, and services coming from the same global sum is unsustainable and cannot continue.”

A CCA spokesperson said: “Community pharmacy has a huge potential to meet the contraceptive needs of women, increasing access and creating much needed capacity across primary care. We have previously highlighted the potential to transfer at least 2 million GP appointments a year to community pharmacy.

Pushing through the rollout of this service, despite the warnings of the negotiator, representative bodies, and contractors shows a worrying disregard for the reality within the community pharmacy sector. The existing contractual agreement was finalised before the pandemic, rampant inflation, ever growing workloads, and continuing pressures on businesses.  Whilst many pharmacies will no-doubt do their best to meet patient needs, the funding of community pharmacy is broken and needs to fundamentally change.

With ambitious commissioning, joint implementation with the sector, and the critical new investment needed, community pharmacy could make a huge impact on women’s contraceptive care. Pharmacy has a history of delivering at scale, and at speed. But the sector cannot continue on goodwill alone.”

NPA Vice-Chair, Nick Kaye: “Pharmacies are convenient and non-stigmatising places to access sexual and reproductive health services.

“Permitting the repeat supply of oral contraception through pharmacies will increase choice and improve access.

“However, the chances of a successful national rollout of the oral contraception service are much reduced by a decade of chronic underfunding which has brought pharmacies across England to crisis point.

“Rather than implementing new NHS services, pharmacy owners are being forced to apply most of their energy to keeping their business afloat.”

Nevertheless, recognising that some pharmacies will want to engage with this service as soon as possible, the NPA has already produced information and resources for its members."

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less